Posts by: Diogo Pinto

News

The Pulmonary Fibrosis Foundation (PFF) is now accepting applications for a new program, called PFF Scholars, that aims to support and further develop promising researchers working in the field ... Read more

September 26, 2018October 2, 2018

Samumed and United Therapeutics Partner to Advance Potential IPF Inhalation Therapy, SM04646

News

Samumed and United Therapeutics announced an exclusive license agreement for North American rights to Samumed’s investigational therapy SM04646 to treat idiopathic pulmonary fibrosis (IPF). Under the agreement, United Therapeutics will ... Read more

September 10, 2018September 12, 2018

University of Arizona Team Receives $4.4M Grant to Test Compounds Targeting IPF

News

A research team from the University of Arizona (UA) College of Medicine – Tucson was given a $4.4 million grant from the U.S. Department of Defense to study two ... Read more

August 17, 2018August 23, 2018

Repeated Lung Cancer Surgery in IPF Patients May Worsen Outcomes

News

Surgery for lung cancer should be carefully considered in patients who also have idiopathic pulmonary fibrosis (IPF), because it is associated with poor outcomes, a study shows. The study, “Survival ... Read more

August 1, 2018August 6, 2018

Enrollment of Pulmonary Fibrosis Foundation Patient Registry is Complete

News

The Pulmonary Fibrosis Foundation (PFF) has completed the enrollment of PF patients in its PFF Patient Registry, with the admission of the 2,002nd patient. Launched in 2016, the PFF Patient Registry ... Read more

July 18, 2018July 18, 2018

Pliant Therapeutics Raises $62M to Develop Promising Therapies for Fibrotic Diseases

News

Pliant Therapeutics raised $62 million in a second round of financing that will be used to support the development of the company’s lead product candidates in fibrotic diseases. The ... Read more

July 11, 2018July 16, 2018

Blood-Oxygen Levels of IPF Patient Sustained for Over 1 Year Using ECMO, Doctors in Japan Report

News

A man with idiopathic pulmonary fibrosis (IPF) was kept alive and his blood oxygenated for more than a year while waiting for a lung transplant using a type of extracorporeal membrane oxygenation ... Read more

July 6, 2018July 11, 2018

Formaldehyde Exposure Linked to Worsening of Pulmonary Fibrosis in Mice Study

News

Formaldehyde, a chemical widely used in construction, health, and manufacturing industries, was seen to worsen lung inflammation and fibrosis in a mouse model of pulmonary fibrosis (PF), a Brazilian ... Read more

June 25, 2018July 12, 2018

New Home Monitoring Program Tested, Approved by IPF Patients in Pilot Study

News

A new, wireless home monitoring program designed to collect data on lung function from patients with idiopathic pulmonary fibrosis (IPF) in real time showed good results and was approved ... Read more

June 19, 2018June 19, 2018

Those Close to IPF Patients Influence Their Acceptance of Disease, UK Study Reports

News

People close to idiopathic pulmonary fibrosis (IPF) patients and those they interact with — from family members and acquaintances to healthcare professionals — influence their acceptance of their disease ... Read more

Posts by: Diogo Pinto

Diogo Pinto

PF Foundation Invites Promising Researchers to Apply to PFF Scholars Program

Samumed and United Therapeutics Partner to Advance Potential IPF Inhalation Therapy, SM04646

University of Arizona Team Receives $4.4M Grant to Test Compounds Targeting IPF

Repeated Lung Cancer Surgery in IPF Patients May Worsen Outcomes

Enrollment of Pulmonary Fibrosis Foundation Patient Registry is Complete

Pliant Therapeutics Raises $62M to Develop Promising Therapies for Fibrotic Diseases

Blood-Oxygen Levels of IPF Patient Sustained for Over 1 Year Using ECMO, Doctors in Japan Report

Formaldehyde Exposure Linked to Worsening of Pulmonary Fibrosis in Mice Study

New Home Monitoring Program Tested, Approved by IPF Patients in Pilot Study

Those Close to IPF Patients Influence Their Acceptance of Disease, UK Study Reports

Pin It on Pinterest